While MRE based on 2D gradient recalled echo (GRE) MRI is FDA approved at 1.5T, the utility of 2D GRE MRE in the liver at 3T is limited by susceptibility effects and relatively long echo times that results in less SNR. MRE performance, particularly at 3T, can be improved by developing a faster technique that is less sensitive to liver T2* effects. In this work, we describe the development of SE-EPI MRE and its validation with respect to 2D GRE MRE in phantoms and healthy volunteers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords